Handbook for Attention Deficit Hyperactivity Disorder in Adults

Front Cover
UKAAN
Springer Science & Business Media, Sep 11, 2013 - Medical - 216 pages
This book is a direct response to a severe treatment gap in recognising, treating and managing attention deficit hyperactivity disorder (ADHD) in adults. Affecting 3–4% of the global population, ADHD has long been considered a pediatric psychiatric condition and continues to be overlooked in adults, who often go on to endure a lifetime of clinically significant impairments that affect work performance, social behavior, and personal relationships. However, in the wake of the recognition of ADHD in adults in the Diagnostic and Statistical Manual of Mental Disorders IV (considered the absolute gold standard in psychiatry) and a greater number of pharmaceutical treatments being indicated for adults, this book will increase awareness of the condition and advocate expanding ADHD treatment across all age ranges. The book is especially relevant to psychiatrists, GPs, and specialist psychiatric nurses , while also a useful resource for patient societies and advocacy groups.
 

Contents

1 Introduction to attention deficithyperactivity disorder
1
2 Definition of attention deficithyperactivity disorder in adults
5
3 The scientific basis of attentiondeficit hyperactivity disorderin adults
17
4 Diagnostic assessment ofattention deficit hyperactivitydisorder in adults
40
5 Neuropsychological assessment
55
6 Comorbid symptoms syndromesand disorders
65
7 Pharmacological treatments
86
8 Psychological treatments
123
Appendix B
172
Appendix C
177
Appendix D
181
Appendix E
183
Appendix F
185
Appendix G
187
Appendix H
206
Appendix I
209

9 Attention deficit hyperactivitydisorder during pregnancy
136
10 Attention deficit hyperactivitydisorder and the criminaljustice system
145
11 Service provision for adultswith attention deficithyperactivity disorder
152
Appendix A
169
Appendix J
212
Appendix K
214
Copyright

Other editions - View all

Common terms and phrases

About the author (2013)

Professor Philip Asherson (MB, BS, MRCPsych, PhD) is Professor of Molecular Psychiatry at the MRC Social, Genetic & Developmental Psychiatry Centre at the Institute of Psychiatry, King’s College London, UK, and consultant psychiatrist at the Maudsley Hospital. He earned his medical degree from The Royal London Hospital and his doctoral degree from the University of Wales. He was an MRC Clinical Research Fellow in the Department of Psychological Medicine and Institute of Medical Genetics at the University Of Wales College Of Medicine in Cardiff, where he worked on molecular genetic studies of schizophrenia. His current work focuses on clinical, quantitative genetic, and molecular genetic studies of ADHD across the lifespan. He has contributed to the development of mental health services for adults with ADHD in the UK. He is President of the UK Adult ADHD Network (www.UKAAN.org), a professional network that aims to support clinical research, education, and service provision for adults with ADHD. He was a member of the guideline development group for the National Institute of Health and Clinical Excellence (NICE) and contributed to published guidelines from NICE, the British Association of Psychopharmacology and the European Network Adult ADHD consensus paper. Current research includes followup studies of ADHD from childhood to adulthood, investigation of mood instability and emotional regulation in ADHD, treatment of ADHD in young offenders, defining the psychopathology of ADHD; and quantitative and molecular genetic studies of ADHD and associated cognitiveneurophysiological endophenotypes. He has published more than 220 peer reviewed articles, including guideline documents on diagnosis and treatment of ADHD in adults.

Bibliographic information